Vision and Mission

Our Vision

Schizophrenia and bipolar disease have a combined presence of approximately 2% in the world’s population, each imparting a devastating affliction to affected individuals and their families. We are focused on clearly understanding the molecular and neuropathological abnormalities of these diseases to reveal precise therapeutic targets upon which effective and well-tolerated pharmacological and other biotechnological treatment strategies can be based.

Our Mission

We maintain efficient and effective organizational strategies in raising funds and providing grants to individual scientists and physicians for advanced research in molecular and neuropathological abnormalities of schizophrenia and bipolar disorder. We are focused on the development of improved management or cure of these diseases, and in generating an invaluable body of peer-reviewed literature and technological innovation.